Stay updated on Moderna Press Releases

Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Moderna Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's stock data updated from $145.55 with 14.97M shares to $143.97 with 15.41M shares.
    Difference
    0.4%
    Check dated 2026-09-12T18:38:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Stock price updated to $145.55 with volume 14.97M. A new press release announcing Moderna's presentation at September 2026 conferences (Sept 1, 2026) has been added, and the prior leadership announcement about Michael McDonnell has been removed (July 8, 2026).
    Difference
    1%
    Check dated 2026-09-05T21:51:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added new press releases to the News and Blog Posts list, including pricing for a $2.6B convertible notes offering, FDA approval for updated 2026-2027 COVID-19 vaccines, and a private placement; older items such as Science Day highlights and advisory committee votes were removed from the listing.
    Difference
    5%
    Check dated 2026-08-29T20:59:51.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a new press release headline about the Merck collaboration and INTerpath-001 trial dated August 19, 2026 to the News page. The header now displays updated stock price and trading volume, and an older organizational-change item was removed.
    Difference
    1%
    Check dated 2026-08-22T21:42:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The header stock information was updated to reflect different price and volume values for Moderna's stock, altering how the market data is presented on the page.
    Difference
    0.4%
    Check dated 2026-08-15T20:25:17.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Two new stock metrics ($59.17 and 6.82M) and two new press releases (FDA approval for the influenza vaccine mFLUSIVA and initiation of Phase 1 trial of mRNA-1469) were added. Older stock data ($54.82 and 7.76M) and a prior press release were removed.
    Difference
    5%
    Check dated 2026-08-08T18:28:20.000Z thumbnail image

Stay in the know with updates to Moderna Press Releases

Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.